BL
Benjamin Looker
Chief Legal Officer

Benjamin Looker insider trades: Esperion Therapeutics (ESPR) stock sales

Chief Legal Officer, Esperion Therapeutics Last trade Jun 17, 2026 18 Form 4 filings
$81K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2023
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Benjamin reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 17, 2026ESPR↓ Sell$37K
Mar 17, 2026ESPR↓ Sell$15K
Jan 20, 2026ESPR↓ Sell$5K
Dec 17, 2025ESPR↓ Sell$24K
Oct 17, 2025ESPR↓ Sell$3K
Sep 17, 2025ESPR↓ Sell$18K
Jul 17, 2025ESPR↓ Sell$1K
Jun 17, 2025ESPR↓ Sell$7K
Apr 19, 2023ESPR↓ Sell$2K
Jan 18, 2023ESPR↓ Sell$44K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ESPR insiders

Open-market trades in the last 12 months

About Benjamin Looker's insider trades

Benjamin Looker is Chief Legal Officer at Esperion Therapeutics (ESPR). Since Jan 18, 2023, Benjamin has reported no open-market purchases and 10 sales worth $157K on SEC Form 4. In the last 12 months: 4 sales ($81K).

Their filings also include grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ESPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.